Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$734M |
| 2 |
Adobe
ADBE
|
+$488M |
| 3 |
Merck
MRK
|
+$443M |
| 4 |
Tesla
TSLA
|
+$366M |
| 5 |
AGN
Allergan plc
AGN
|
+$315M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$682M |
| 2 |
Perrigo
PRGO
|
+$585M |
| 3 |
Gilead Sciences
GILD
|
+$556M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$432M |
| 5 |
Morgan Stanley
MS
|
+$401M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.94% |
| 2 | Consumer Discretionary | 14.99% |
| 3 | Communication Services | 11.27% |
| 4 | Technology | 9.94% |
| 5 | Financials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Duke Energy
DUK
$101B
| $51.5M | 0.05% |
746,335
| – | – |
|
302
Old Dominion Freight Line
ODFL
$46.3B
| $50.9M | 0.05% |
+2,880,924
| New | +$47.3M |
|
303
Semtech
SMTC
$9.65B
| $50.7M | 0.05% |
2,004,722
-53,893
| -3% | -$1.59M |
|
|
MDCO
304
DELISTED
Medicines Co
MDCO
| $50.6M | 0.05% |
1,311,000
+12,098
| +0.9% | +$433K |
|
305
Norwegian Cruise Line
NCLH
$9.53B
| $50.6M | 0.05% |
1,427,318
+112,836
| +9% | +$3.66M |
|
|
GLDD
306
DELISTED
Great Lakes Dredge & Dock
GLDD
| $49.6M | 0.05% |
5,390,689
-238,988
| -4% | -$2M |
|
|
PINC
307
DELISTED
Premier
PINC
| $49.5M | 0.05% |
+1,347,847
| New | +$44.5M |
|
|
NIHD
308
DELISTED
NII HOLDINGS INC CL B
NIHD
| $49.5M | 0.05% |
17,997,767
-3,688,860
| -17% | -$13.6M |
|
309
Korn Ferry
KFY
$4.31B
| $49.3M | 0.05% |
1,887,734
-145,412
| -7% | -$3.45M |
|
|
HITT
310
DELISTED
HITTITE MICROWAVE CORP
HITT
| $49.2M | 0.05% |
796,408
-155,588
| -16% | -$9.73M |
|
311
American Airlines Group
AAL
$9.82B
| $48.9M | 0.05% |
+1,938,298
| New | +$49.9M |
|
312
National Grid
NGG
$79.3B
| $48.7M | 0.05% |
772,604
| – | – |
|
313
Annaly Capital Management
NLY
$17.3B
| $48.2M | 0.05% |
1,207,538
-433,494
| -26% | -$18.8M |
|
314
Acadia Healthcare
ACHC
$2.52B
| $47.8M | 0.05% |
1,010,502
-27,771
| -3% | -$1.21M |
|
315
Adecoagro
AGRO
$1.4B
| $47.6M | 0.05% |
5,878,145
+244,674
| +4% | +$1.94M |
|
|
MWIV
316
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| $47.5M | 0.05% |
278,256
-26,820
| -9% | -$4.45M |
|
317
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $47.4M | 0.05% |
1,457,880
-83,294
| -5% | -$2.63M |
|
|
NVDQ
318
DELISTED
Novadaq Technologies Inc.
NVDQ
| $47.3M | 0.05% |
2,869,779
+184,523
| +7% | +$3.06M |
|
|
EVHC
319
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $46.9M | 0.05% |
441,184
+99,418
| +29% | +$8.95M |
|
320
Korea Electric Power
KEP
$14.6B
| $46.8M | 0.05% |
2,820,161
-459,980
| -14% | -$6.63M |
|
|
ESV
321
DELISTED
Ensco Rowan plc
ESV
| $46.5M | 0.05% |
203,098
-2,616
| -1% | -$604K |
|
|
CIR
322
DELISTED
CIRCOR International, Inc
CIR
| $46.2M | 0.05% |
571,336
-7,008
| -1% | -$511K |
|
323
Ameren
AEE
$30.4B
| $45.9M | 0.05% |
1,269,838
+403,156
| +47% | +$14.5M |
|
324
Waste Management
WM
$95B
| $45.7M | 0.04% |
1,019,399
| – | – |
|
|
GOLD
325
DELISTED
Randgold Resources Ltd
GOLD
| $45.3M | 0.04% |
731,973
-17,267
| -2% | -$1.19M |
|
Similar funds
Jennison Associates's Q4 2013 Portfolio in Review
As of Q4 2013, Jennison Associates held 759 positions worth $102B, up 6.9% from $95.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jennison Associates's Q4 2013 filing shows 79 new, 184 increased, 411 reduced and 54 closed positions. Its largest new stake was Allergan plc: 2,016,619 shares worth $339M. The largest sale was UnitedHealth, an estimated $682M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q4 2013 buy was Allergan plc: 2,016,619 shares worth $339M.
- Jennison Associates added most to Bristol-Myers Squibb in Q4 2013, an estimated $734M increase.
- Jennison Associates's biggest Q4 2013 reduction was UnitedHealth, cutting an estimated $682M.
- Jennison Associates fully exited Perrigo in Q4 2013, selling an estimated $585M.
- Jennison Associates's ten largest holdings make up 20% of its $102B portfolio in Q4 2013.
- Jennison Associates opened 79 new positions and closed 54 in Q4 2013.
- Jennison Associates's portfolio value rose 6.9% quarter-over-quarter to $102B.
Based on Jennison Associates's 13F filing for Q4 2013, filed 10 Feb 2014.